Loading…
A week 45 market report said earnings at Meihua Bio and Xinghu Technology fell sharply in the first three quarters of 2026, with both companies citing higher volumes but lower prices for core products including lysine and threonine. Domestic prices for 70% and 98% lysine were described as steady to slightly weaker, squeezing industry margins.
Weak lysine prices pressure producer margins and may encourage buyers to monitor offers and purchasing needs closely. The reported softness points to a bearish price signal for lysine.
scpfsw.comNov 7, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
